Prognostic significance of SUV on PET/CT in patients with esophageal cancer: a systematic review and meta-analysis.
about
Prognostic Value of 18F-FDG PET/CT in Surgical Non-Small Cell Lung Cancer: A Meta-AnalysisThe value of [18F]fluorodeoxyglucose-PET/CT in oesophageal cancerPhase II Study of Irinotecan and Cisplatin Combination Chemotherapy in Metastatic, Unresectable Esophageal CancerPrognostic value of baseline FDG uptake on PET-CT in esophageal carcinomaPrognostic Value of Metabolic Activity Measured by (18)F-FDG PET/CT in Patients with Advanced Endometrial CancerUtilisation of search filters in systematic reviews of prognosis questions.The maximum standardized uptake value of 18 F-FDG PET scan to determine prognosis of hormone-receptor positive metastatic breast cancerA prospective evaluation of the utility of 2-deoxy-2-[(18) F]fluoro-D-glucose positron emission tomography and computed tomography in staging locally advanced gastric cancer.The Role of 18F-FDG PET/CT in the Primary Staging of Gastric CancerMetabolic Characteristics of Advanced Biliary Tract Cancer Using 18F-Fluorodeoxyglucose Positron Emission Tomography and Their Clinical ImplicationsPositron emission tomography with [(18)F]-3'-deoxy-3'fluorothymidine (FLT) as a predictor of outcome in patients with locally advanced resectable rectal cancer: a pilot studyRole of Pre-therapeutic (18)F-FDG PET/CT in Guiding the Treatment Strategy and Predicting Prognosis in Patients with Esophageal Carcinoma.Incorporating prognostic imaging biomarkers into clinical practice.Variations in positron emission tomography-computed tomography findings for patients receiving neoadjuvant and non-neoadjuvant therapy for non-small cell lung cancer.Maximum standardized uptake value on PET/CT in preoperative assessment of lymph node metastasis from thoracic esophageal squamous cell carcinoma.A new dimension of FDG-PET interpretation: assessment of tumor biology.The challenges of integrating molecular imaging into the optimization of cancer therapy.Role of ¹⁸F 2-fluoro-2-deoxyglucose positron emission tomography in upper gastrointestinal malignancies.Prognostic significance of SUV on PET/CT in patients with localised oesophagogastric junction cancer receiving neoadjuvant chemotherapy/chemoradiation:a systematic review and meta-analysis.Multiparametric PET/CT in oncology.Curative treatment of esophageal cancer; an evidenced based review.Prognostic value of volumetric parameters of (18)F-FDG PET in non-small-cell lung cancer: a meta-analysis.State-of-the-art molecular imaging in esophageal cancer management: implications for diagnosis, prognosis, and treatment.Prognostic value of pretreatment 18F-FDG PET-CT for nasopharyngeal carcinoma patients.Beyond Correlations, Sensitivities, and Specificities: Case Examples of the Evaluation of Advanced Imaging in Oncology Clinical Trials and Cancer Treatment.The prognostic value of fluorodeoxyglucose positron emission tomography metabolic tumor volume in solitary colorectal liver metastasis.PET/CT predicts survival in patients undergoing primary surgery for esophageal cancer.Comparison of novel multi-level Otsu (MO-PET) and conventional PET segmentation methods for measuring FDG metabolic tumor volume in patients with soft tissue sarcoma.Prognostic value of maximum standard uptake value, metabolic tumor volume, and total lesion glycolysis of positron emission tomography/computed tomography in patients with nasopharyngeal carcinoma: A systematic review and meta-analysis.Quantitative FDG-PET/CT predicts local recurrence and survival for squamous cell carcinoma of the anus.Present and future roles of FDG-PET/CT imaging in the management of gastrointestinal cancer: an update.The prognostic value of 18F-FDG PET/CT prior to liver transplantation for nonresectable colorectal liver metastases.Prognostic value of metabolic volume measured by F-18 FDG PET-CT in patients with esophageal cancer.The prognostic value of total lesion glycolysis via 18F-fluorodeoxyglucose PET-CT in surgically treated esophageal squamous cell carcinoma.The correlation between the metabolic tumor volume and hematological parameters in patients with esophageal cancer.Standardized uptake value by positron emission tomography/computed tomography as a prognostic variable in metastatic breast cancer.Accuracy of PET-CT in predicting survival in patients with esophageal cancer.Clinical significance of SUVmax on preoperative 18F-fluorodeoxyglucose positron emission tomography in patients who underwent R0-esophagectomy for esophageal cancer
P2860
Q26771327-3307E7EF-71CC-4144-9F93-8E9C7FEE1681Q26864611-4AA15B15-49C0-4FF1-94F4-C9B669794398Q33434339-8C30A912-41D4-47FD-A73C-AB723244B217Q33612675-FB8AF0DB-165C-460A-9A36-719C2B2ED251Q33669870-7125132C-F2D2-4B95-9596-232EB8004F5FQ34486542-64B4AD91-4EEB-412D-B852-E6740B5790F6Q34569318-F97B616B-1007-4D5F-8187-20CDA617B37BQ34637906-3EE7BF66-5B63-4367-AB9B-83395E313737Q35214843-709D6E2D-FCE5-4C72-9366-91F2FCAC7348Q35915703-B37E38C2-75DB-4C94-9AF5-A4CABA235AD0Q36861827-F816525C-BFC5-471A-BC70-6BF7FBA225CFQ37080068-7F9477D8-666C-49A8-9A85-244ADF0DFAFBQ37193816-98A6155C-D3F1-4C37-88FE-00B633F0F0ACQ37677609-6D71606B-C159-430B-AFB3-737D22911B0AQ37683707-2FE160CF-3A92-4CCB-823E-72FA298C7430Q37827752-D373C2C4-8385-4CDA-9DAF-E3691C7426BCQ37871875-8F92410A-69B6-4BF2-81F9-28EBDF287524Q37968594-D54AE3BA-918F-4B7E-A546-989F6B505F58Q37984273-266E0B9E-3D06-417B-86BB-5D054151AA97Q38047768-0E875F03-6519-4048-93A6-3D2569087DE2Q38119170-A70F094A-30ED-46B4-96B7-9F2E7215FBD6Q38246442-D17A3BDD-8C96-4827-BE65-55850BEB0978Q38340518-9599B725-470C-4061-9E69-50BE60F196D5Q38818668-F09F417E-48DC-4761-9BDB-24182D4BAFEEQ38836364-2E46F876-FA88-4552-8618-02699B72E844Q39566044-F7D9493C-8CC5-44F9-8745-8E672BD8AAA4Q41603352-8CEA5EA2-EAE6-411F-AD69-7E7CF975157DQ41683896-FD19D8A9-62DF-4DB9-ACAA-C2D6105B0C5CQ42360793-84C46000-D668-4084-96BF-64A269AFAC5FQ43379654-9B5EE29F-E118-43C4-A77E-C071CF83545BQ47108211-92F3E2D9-8ED9-4FC4-9359-36BCAD71E515Q48194435-DA7D35EF-42B9-405C-B7C3-59608A9B7BBCQ50050115-81F67817-2209-4547-A856-1FA5F87B4682Q52989904-B0158C61-2973-4EF1-A34A-144415686071Q52991470-7DB9BD34-4EB4-4242-89A0-DEB2A4383031Q53165455-5E927299-901F-4B15-A7A6-8BB7EF985B9DQ53173085-4DCECC1F-96D6-4046-962C-B487BBB45122Q58804714-69BC7D8A-8E07-4C0A-8337-84CA726D6D42
P2860
Prognostic significance of SUV on PET/CT in patients with esophageal cancer: a systematic review and meta-analysis.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on September 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Prognostic significance of SUV ...... atic review and meta-analysis.
@en
Prognostic significance of SUV ...... atic review and meta-analysis.
@nl
type
label
Prognostic significance of SUV ...... atic review and meta-analysis.
@en
Prognostic significance of SUV ...... atic review and meta-analysis.
@nl
prefLabel
Prognostic significance of SUV ...... atic review and meta-analysis.
@en
Prognostic significance of SUV ...... atic review and meta-analysis.
@nl
P2093
P1476
Prognostic significance of SUV ...... atic review and meta-analysis.
@en
P2093
P304
P356
10.1097/MEG.0B013E328323D6FA
P577
2009-09-01T00:00:00Z